These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36011296)

  • 1.
    Kosac A; Pesovic J; Radenkovic L; Brkusanin M; Radovanovic N; Djurisic M; Radivojevic D; Mladenovic J; Ostojic S; Kovacevic G; Kravljanac R; Savic Pavicevic D; Milic Rasic V
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants.
    van den Bergen JC; Hiller M; Böhringer S; Vijfhuizen L; Ginjaar HB; Chaouch A; Bushby K; Straub V; Scoto M; Cirak S; Humbertclaude V; Claustres M; Scotton C; Passarelli C; Lochmüller H; Muntoni F; Tuffery-Giraud S; Ferlini A; Aartsma-Rus AM; Verschuuren JJ; 't Hoen PA; Spitali P
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1060-5. PubMed ID: 25476005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy.
    Bello L; Flanigan KM; Weiss RB; ; Spitali P; Aartsma-Rus A; Muntoni F; Zaharieva I; Ferlini A; Mercuri E; Tuffery-Giraud S; Claustres M; Straub V; Lochmüller H; Barp A; Vianello S; Pegoraro E; Punetha J; Gordish-Dressman H; Giri M; McDonald CM; Hoffman EP;
    Am J Hum Genet; 2016 Nov; 99(5):1163-1171. PubMed ID: 27745838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy.
    Barp A; Bello L; Politano L; Melacini P; Calore C; Polo A; Vianello S; Sorarù G; Semplicini C; Pantic B; Taglia A; Picillo E; Magri F; Gorni K; Messina S; Vita GL; Vita G; Comi GP; Ermani M; Calvo V; Angelini C; Hoffman EP; Pegoraro E
    PLoS One; 2015; 10(10):e0141240. PubMed ID: 26513582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study.
    Bello L; Kesari A; Gordish-Dressman H; Cnaan A; Morgenroth LP; Punetha J; Duong T; Henricson EK; Pegoraro E; McDonald CM; Hoffman EP;
    Ann Neurol; 2015 Apr; 77(4):684-96. PubMed ID: 25641372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Modifiers and Phenotype of Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis.
    Pascual-Morena C; Cavero-Redondo I; Saz-Lara A; Sequí-Domínguez I; Lucerón-Lucas-Torres M; Martínez-Vizcaíno V
    Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Modifiers of Duchenne Muscular Dystrophy in Chinese Patients.
    Chen M; Wang L; Li Y; Chen Y; Zhang H; Zhu Y; He R; Li H; Lin J; Zhang Y; Zhang C
    Front Neurol; 2020; 11():721. PubMed ID: 32849198
    [No Abstract]   [Full Text] [Related]  

  • 8. LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy.
    Flanigan KM; Ceco E; Lamar KM; Kaminoh Y; Dunn DM; Mendell JR; King WM; Pestronk A; Florence JM; Mathews KD; Finkel RS; Swoboda KJ; Gappmaier E; Howard MT; Day JW; McDonald C; McNally EM; Weiss RB;
    Ann Neurol; 2013 Apr; 73(4):481-8. PubMed ID: 23440719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic modifiers of respiratory function in Duchenne muscular dystrophy.
    Bello L; D'Angelo G; Villa M; Fusto A; Vianello S; Merlo B; Sabbatini D; Barp A; Gandossini S; Magri F; Comi GP; Pedemonte M; Tacchetti P; Lanzillotta V; Trucco F; D'Amico A; Bertini E; Astrea G; Politano L; Masson R; Baranello G; Albamonte E; De Mattia E; Rao F; Sansone VA; Previtali S; Messina S; Vita GL; Berardinelli A; Mongini T; Pini A; Pane M; Mercuri E; Vianello A; Bruno C; Hoffman EP; Morgenroth L; Gordish-Dressman H; McDonald CM; ; Pegoraro E
    Ann Clin Transl Neurol; 2020 May; 7(5):786-798. PubMed ID: 32343055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-range genomic regulators of THBS1 and LTBP4 modify disease severity in duchenne muscular dystrophy.
    Weiss RB; Vieland VJ; Dunn DM; Kaminoh Y; Flanigan KM;
    Ann Neurol; 2018 Aug; 84(2):234-245. PubMed ID: 30014611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IAAM LTBP4 Haplotype is Protective Against Dystrophin-Deficient Cardiomyopathy.
    Bello L; Sabbatini D; Fusto A; Gorgoglione D; Borin GU; Penzo M; Riguzzi P; Villa M; Vianello S; Calore C; Melacini P; Vio R; Barp A; D'Angelo G; Gandossini S; Politano L; Berardinelli A; Messina S; Vita GL; Pedemonte M; Bruno C; Albamonte E; Sansone V; Baranello G; Masson R; Astrea G; D'Amico A; Bertini E; Pane M; Lucibello S; Mercuri E; Spurney C; Clemens P; Morgenroth L; Gordish-Dressman H; McDonald CM; Hoffman EP; ; Pegoraro E
    J Neuromuscul Dis; 2024; 11(2):285-297. PubMed ID: 38363615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DMD mutation and LTBP4 haplotype do not predict onset of left ventricular dysfunction in Duchenne muscular dystrophy.
    Van Dorn CS; Puchalski MD; Weng HY; Bleyl SB; Butterfield RJ; Williams RV
    Cardiol Young; 2018 Jul; 28(7):910-915. PubMed ID: 29766838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Loss of Ambulation in Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis.
    Landfeldt E; Alemán A; Abner S; Zhang R; Werner C; Tomazos I; Ferizovic N; Lochmüller H; Kirschner J
    J Neuromuscul Dis; 2024; 11(3):579-612. PubMed ID: 38669554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of polymorphisms rs2303729, rs10880, and rs1131620 of
    Ibarra-Tapia IY; Juárez-Sandoval A; Pérez IT; Cano-Martínez LJ; Sánchez-García S; Ruiz-Batalla JM; Aroche-Reyes IA; García S; Canto P; Mejía DR; Coral-Vázquez RM
    Ann Hum Biol; 2022 Dec; 49(7-8):311-316. PubMed ID: 36524797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic modifiers of upper limb function in Duchenne muscular dystrophy.
    Sabbatini D; Fusto A; Vianello S; Villa M; Janik J; D'Angelo G; Diella E; Magri F; Comi GP; Panicucci C; Bruno C; D'Amico A; Bertini E; Astrea G; Battini R; Politano L; Masson R; Baranello G; Previtali SC; Messina S; Vita G; Berardinelli A; Mongini T; Pini A; Pane M; Mercuri E; Hoffman EP; Morgenroth L; Gordish-Dressman H; Duong T; McDonald CM; Bello L; Pegoraro E
    J Neurol; 2022 Sep; 269(9):4884-4894. PubMed ID: 35513612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene.
    Licandro SA; Crippa L; Pomarico R; Perego R; Fossati G; Leoni F; Steinkühler C
    Skelet Muscle; 2021 Jul; 11(1):19. PubMed ID: 34294164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifier genes and their effect on Duchenne muscular dystrophy.
    Vo AH; McNally EM
    Curr Opin Neurol; 2015 Oct; 28(5):528-34. PubMed ID: 26263473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells.
    Vianello S; Pantic B; Fusto A; Bello L; Galletta E; Borgia D; Gavassini BF; Semplicini C; Sorarù G; Vitiello L; Pegoraro E
    Hum Mol Genet; 2017 Sep; 26(17):3342-3351. PubMed ID: 28595270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outside in: The matrix as a modifier of muscular dystrophy.
    Quattrocelli M; Spencer MJ; McNally EM
    Biochim Biophys Acta Mol Cell Res; 2017 Mar; 1864(3):572-579. PubMed ID: 28011285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ.
    Lamar KM; Bogdanovich S; Gardner BB; Gao QQ; Miller T; Earley JU; Hadhazy M; Vo AH; Wren L; Molkentin JD; McNally EM
    PLoS Genet; 2016 May; 12(5):e1006019. PubMed ID: 27148972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.